FdaApplication
BLA 761322
Identifiers
- fda_app_no: BLA761322
Properties
| Property | Value |
|---|---|
| applicant_name | Sandoz Inc. |
| application_type | BLA |
| approval_date | 2023-08-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TYRUKO | NATALIZUMAB-SZTN | 300MG/15ML (20MG/ML) | Injection |
1 product